BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36533574)

  • 1. Store-operated Ca
    Tao Y; Mallet RT; Mathis KW; Ma R
    Exp Biol Med (Maywood); 2023 May; 248(5):425-433. PubMed ID: 36533574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-activated store-operated Ca
    Kim JH; Hwang KH; Dang BTN; Eom M; Kong ID; Gwack Y; Yu S; Gee HY; Birnbaumer L; Park KS; Cha SK
    Nat Commun; 2021 Nov; 12(1):6537. PubMed ID: 34764278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Store-operated Ca
    Tao Y; Yazdizadeh Shotorbani P; Inman D; Das-Earl P; Ma R
    Am J Physiol Renal Physiol; 2023 May; 324(5):F494-F504. PubMed ID: 36995925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reorganization and Suppression of Store-Operated Calcium Entry in Podocytes of Type 2 Diabetic Rats.
    Gusev K; Shalygin A; Kolesnikov D; Shuyskiy L; Makeenok S; Glushankova L; Sivak K; Yakovlev K; Orshanskaya Y; Wang G; Bakhtyukov A; Derkach K; Shpakov A; Kaznacheyeva E
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Store-operated calcium entry: Pivotal roles in renal physiology and pathophysiology.
    Chaudhari S; Mallet RT; Shotorbani PY; Tao Y; Ma R
    Exp Biol Med (Maywood); 2021 Feb; 246(3):305-316. PubMed ID: 33249888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
    Sever S; Schiffer M
    Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy.
    Jiang H; Shen Z; Zhuang J; Lu C; Qu Y; Xu C; Yang S; Tian X
    Front Immunol; 2023; 14():1335936. PubMed ID: 38288116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.
    Li G; Kidd J; Li PL
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress on exosomes in podocyte injury associated with diabetic kidney disease.
    Li J; Zheng S; Ma C; Chen X; Li X; Li S; Wang P; Chen P; Wang Z; Li W; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1129884. PubMed ID: 37020588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Physiopathologic Roles of Calcium Signaling in Podocytes.
    Tu YC; Shu HP; Sun LL; Liao QQ; Feng L; Ren M; Yao LJ
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):240. PubMed ID: 37919067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stromal interaction molecule 1 or Orai1 overexpression on the associated proteins and permeability of podocytes.
    Miao L; Wei D; Zhang Y; Liu J; Lu S; Zhang A; Huang S
    Nephrology (Carlton); 2016 Nov; 21(11):959-967. PubMed ID: 26715123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
    Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
    Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease.
    Zha D; Wu X
    J Nephrol; 2023 Jan; 36(1):17-29. PubMed ID: 35704261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy.
    Nishad R; Mukhi D; Tahaseen SV; Mungamuri SK; Pasupulati AK
    J Biol Chem; 2019 Nov; 294(44):16109-16122. PubMed ID: 31511328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose promotes podocyte movement: From the perspective of single cell motility assay.
    Zhang J; Zhang Y; Zhang Q; Feng Y; Deng X; Deng F; Chen B; Hu J
    Cell Biol Int; 2023 Apr; 47(4):823-830. PubMed ID: 36701327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
    Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
    Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.